These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

According to the company's statement, these medications are designed to improve glycemic control in adults with Type 2 Diabetes while also reducing cardiovascular outcomes in the patients.

The country's top specialty generics company recently acquired US-based Checkpoint that will further its oncology portfolio ...

Macquarie, Nomura, Kotak Institutional Equities, Kotak Institutional Equities, Morgan Stanley, HSBC ...